A dipstick test for joint infection? study puts cheap diagnostics to the test
NCT ID NCT07718386
First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time
Summary
This study investigates whether three common lab tests — blood levels of ESR and CRP, plus a leukocyte esterase dipstick test on joint fluid — can reliably diagnose chronic infection in people who have had a total joint replacement. The researchers will compare the test results against standard diagnostic criteria in 80 patients who may have a periprosthetic joint infection. If accurate, these inexpensive tests could simplify diagnosis and speed up treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If these tests prove accurate, diagnosing chronic joint infections could become faster, cheaper, and more accessible.
- What could go wrong
- This is a small, single-center study. The tests may not be accurate enough to replace current methods, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
80 people
The number who actually took part.
- Started
-
Dec 2022
- Finished
-
May 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Infected and query infected TJR patients Time of presentation \>=4 weeks post op. Exclusion Criteria: presentation before 4 weeks post op Hematogenous infections Patients with infection elsewhere in the body Patients with inflammatory arthritis as gouty arthritis, SLE and RA.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Periprosthetic joint infection (PJI) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ain Shams University hospitals
Cairo, Abbasya, 11566, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a prostate drug stop shoulder infections before they start?
- Sound waves and bubbles take on stubborn joint infections
- Blood markers may predict joint infection treatment success
- Which surgery best fights knee replacement infections? study digs into data
- New injection could fight stubborn joint infections after knee surgery